Literature DB >> 34090388

A new modified Gant-Miwa-Thiersch combined with submucosal and perirectal sclerosant injection procedure for full-thickness rectal prolapse in elderly women: clinical analysis of 34 cases.

Jinxi Wang1, Huiyu Li1, Xiaoming Ma2, Gang Du1, Jun Ma1, Xiaojing Ren1, Fang Zhang1, Xiushan Dong1, Haoliang Zhao1, Chongren Ren3,4.   

Abstract

BACKGROUND: Full-thickness rectal prolapse (FTRP) frequently occurs in elderly women, and more than 100 surgical procedures have been proposed to restore FTRP. The Gant-Miwa-Thiersch (GMT) procedure is the most used treatment in China. However, the recurrence rate of FTRP post-GMT, which is as high as 23.8%, is concerning. We described a new modified GMT combined with internal and external rectal sclerosant injection (nmGMTSI) procedure to address this problem.
METHODS: The nmGMTSI was performed under spinal anesthesia in 34 frail, elderly female patients with FTRP. The surgical results of FTRP were assessed. Fecal incontinence and constipation were evaluated using the Wexner score, and anal canal rest pressure (ACRP), maximum anal systolic pressure (MASP), anorectal sensation thresholds (AST), and maximum rectal tolerance (MRT) using anorectal manometry preoperatively and postoperatively. The causes of recurrence and complications were analyzed.
RESULTS: All patients were cured according to the clinical cure standard. The perioperative Wexner fecal incontinence score (WFIS) was 10.3 ± 3.31, which became 3.7 ± 2.43 (P < 0.0001) postoperatively. The perioperative ACRP was 2.0 ± 0.56 kPa, which became 8.5 ± 2.25 kPa (P < 0.0001) postoperatively. The perioperative MASP was 4.5 ± 1.16 kPa, which became 18.6 ± 2.50 kPa (P < 0.0001) postoperatively. However, no significant difference was observed between the preoperative and postoperative Wexner constipation scores (WCS) (17.3 ± 2.25 vs. 15.4 ± 2.89, P = 0.1047). The perioperative and postoperative AST were 38.1 ± 5.34 mL and 23.5 ± 3.61 mL, respectively (P = 0.0002). The maximum rectal tolerance (MRT) was 157.1 ± 16.73 mL, which became 121.2 ± 12.45 mL postoperatively (P = 0.0009). The patients developed no serious postoperative complications. The total relapse rate after nmGMTSI was 2.9% in the median two years follow-up period. The most common cause of relapse after nmGMTSI was the removal of infected threads used in the Thiersch procedure.
CONCLUSION: The benefits of nmGMTSI include low rates of recurrence, complications, and mortality, cost-effectiveness, wide adaptation, minimal invasiveness, and technical simplicity. Hence, it should be considered the first option for the treatment of FTRP in frail elderly women.

Entities:  

Keywords:  Full-thickness rectal prolapse; Gant-Miwa-Thiersch procedure; Rectal prolapse; Recurrence; nmGMTSI

Mesh:

Substances:

Year:  2021        PMID: 34090388     DOI: 10.1186/s12893-021-01284-2

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


  4 in total

1.  Long-term outcome of stapled transanal rectal resection (STARR) versus stapled hemorrhoidopexys (STH) for grade III-IV hemorrhoids: preliminary results.

Authors:  Simone Zanella; Saverio Spirch; Marco Scarpa; Francesco Ricci; Franco Lumachi
Journal:  In Vivo       Date:  2014 Nov-Dec       Impact factor: 2.155

Review 2.  Mucosal plication (Gant-Miwa procedure) with anal encircling for rectal prolapse--a review of the Japanese experience.

Authors:  Tetsuo Yamana; Junichi Iwadare
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

3.  [Clinical analysis of 31 cases with rectal prolapse undergoing modified Gant-Miwa procedure and anal encircling].

Authors:  Zhong Shen; Guan-gen Yang; Xiu-feng Zhang; Jian-ming Qiu; Yan-yan Yu
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2013-07

4.  MMP-1/TIMP-1 expressions in rectal submucosa of females with obstructed defecation syndrome associated with internal rectal prolapse.

Authors:  Long-Lei Cao; Jie Yu; Zhang-Ling Yang; Xu Qiao; Hui Ye; Chang-Lei Xi; Qi-Chang Zhou; Cheng-Cheng Hu; Chao-Jun Zhao; Zhi-Lin Gong
Journal:  Histol Histopathol       Date:  2018-09-17       Impact factor: 2.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.